The_DT
estrogen_NN
receptor_NN
codon_NN
10_CD
polymorphism_NN
detected_VBN
in_IN
breast_NN
cancer_NN
is_VBZ
also_RB
present_JJ
in_IN
non-malignant_JJ
cells_NNS
._.

The_DT
effect_NN
of_IN
estrogens_NNS
on_IN
oestrogen-receptive_JJ
organs_NNS
and_CC
cells_NNS
is_VBZ
mediated_VBN
via_IN
intracellular_JJ
receptors_NNS
-LRB-_-LRB-
ERalpha_NN
and_CC
ERbeta_NN
-RRB-_-RRB-
._.

Oestrogen_NN
receptor_NN
gene_NN
polymorphisms_NNS
in_IN
the_DT
region_NN
encoding_VBG
the_DT
N-terminal_JJ
portion_NN
of_IN
the_DT
protein_NN
are_VBP
reportedly_RB
associated_VBN
with_IN
pathological_JJ
conditions_NNS
including_VBG
breast_NN
cancer_NN
,_,
hypertension_NN
,_,
spontaneous_JJ
abortion_NN
and_CC
coronary_JJ
heart_NN
disease_NN
._.

A_DT
silent_JJ
mutation_NN
in_IN
codon_NN
10_CD
of_IN
exon_NN
1_CD
,_,
detected_VBN
in_IN
ER-negative_JJ
and_CC
ER-positive_JJ
human_JJ
breast_NN
cancer_NN
cell_NN
lines_NNS
,_,
in_IN
breast_NN
tumors_NNS
and_CC
blood_NN
DNA_NN
from_IN
breast_NN
cancer_NN
patients_NNS
,_,
has_VBZ
been_VBN
recognized_VBN
as_IN
a_DT
polymorphic_JJ
site_NN
._.

In_IN
this_DT
study_NN
we_PRP
examined_VBD
,_,
by_IN
denaturing_VBG
gradient-gel_JJ
electrophoresis_NN
and_CC
DNA_NN
sequence_NN
analysis_NN
,_,
the_DT
possible_JJ
presence_NN
of_IN
a_DT
codon_NN
10_CD
polymorphic_JJ
site_NN
in_IN
normal_JJ
estrogen_NN
target_NN
organs_NNS
and_CC
cells_NNS
such_JJ
as_IN
the_DT
uterus_NN
-LRB-_-LRB-
myometrium_NN
and_CC
endometrium_NN
-RRB-_-RRB-
,_,
in_IN
the_DT
placenta_NN
and_CC
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
and_CC
in_IN
a_DT
benign_JJ
uterus_NN
tumor_NN
-LRB-_-LRB-
leiomyoma_NN
-RRB-_-RRB-
._.

We_PRP
have_VBP
detected_VBN
ER_NN
codon_NN
10_CD
polymorphism_NN
in_IN
these_DT
samples_NNS
and_CC
have_VBP
compared_VBN
them_PRP
to_TO
those_DT
observed_VBN
in_IN
breast_NN
cancer_NN
samples_NNS
._.

All_DT
tissues_NNS
and_CC
cells_NNS
studied_VBN
were_VBD
homozygous_JJ
for_IN
the_DT
wild-type_JJ
gene_NN
,_,
and_CC
were_VBD
heterozygous_JJ
as_RB
well_RB
as_IN
homozygous_JJ
for_IN
the_DT
codon-10-variant_JJ
type_NN
._.

These_DT
results_NNS
indicate_VBP
that_IN
the_DT
presence_NN
of_IN
the_DT
codon-10-variant_JJ
type_NN
is_VBZ
not_RB
a_DT
characteristic_NN
of_IN
breast_NN
cancer_NN
._.

Out_IN
current_JJ
findings_NNS
suggest_VBP
that_IN
further_JJ
investigations_NNS
are_VBP
warranted_VBN
to_TO
elucidate_VB
the_DT
possible_JJ
linkage_NN
of_IN
ER_NN
codon_NN
10_CD
polymorphism_NN
to_TO
physiological_JJ
and_CC
pathological_JJ
conditions_NNS
._.

